Cite
Zewde MG, Morales G, Gandhi I, et al. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease. Transplant Cell Ther. 2021;27(12):988.e1-988.e7doi: 10.1016/j.jtct.2021.08.021.
Zewde, M. G., Morales, G., Gandhi, I., Özbek, U., Aguayo-Hiraldo, P., Ayuk, F., Baez, J., Chanswangphuwana, C., Choe, H., DeFilipp, Z., Etra, A., Grupp, S., Hexner, E. O., Hogan, W., Javorniczky, N. R., Kasikis, S., Kitko, C. L., Kowalyk, S., Meedt, E., Merli, P., Nakamura, R., Qayed, M., Reshef, R., Rösler, W., Schechter, T., Weber, D., Wölfl, M., Yanik, G., Young, R., Levine, J. E., Ferrara, J. L. M., & Chen, Y. B. (2021). Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease. Transplantation and cellular therapy, 27(12), 988.e1-988.e7. https://doi.org/10.1016/j.jtct.2021.08.021
Zewde, Makda Getachew, et al. "Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease." Transplantation and cellular therapy vol. 27,12 (2021): 988.e1-988.e7. doi: https://doi.org/10.1016/j.jtct.2021.08.021
Zewde MG, Morales G, Gandhi I, Özbek U, Aguayo-Hiraldo P, Ayuk F, Baez J, Chanswangphuwana C, Choe H, DeFilipp Z, Etra A, Grupp S, Hexner EO, Hogan W, Javorniczky NR, Kasikis S, Kitko CL, Kowalyk S, Meedt E, Merli P, Nakamura R, Qayed M, Reshef R, Rösler W, Schechter T, Weber D, Wölfl M, Yanik G, Young R, Levine JE, Ferrara JLM, Chen YB. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease. Transplant Cell Ther. 2021 Dec;27(12):988.e1-988.e7. doi: 10.1016/j.jtct.2021.08.021. Epub 2021 Aug 30. PMID: 34474163.
Copy
Download .nbib